Capital Impact Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-24,637
| Closed | -$809K | – | 180 |
|
|
2016
Q4 | $809K | Hold |
24,637
| – | – | 0.34% | 175 |
|
|
2016
Q3 | $777K | Hold |
24,637
| – | – | 0.34% | 174 |
|
|
2016
Q2 | $693K | Hold |
24,637
| – | – | 0.32% | 183 |
|
|
2016
Q1 | $896K | Hold |
24,637
| – | – | 0.43% | 129 |
|
|
2015
Q4 | $986K | Buy |
24,637
+11,000
| +81% | +$440K | 0.47% | 61 |
|
|
2015
Q3 | $389K | Hold |
13,637
| – | – | 0.2% | 186 |
|
|
2015
Q2 | $449K | Hold |
13,637
| – | – | 0.2% | 202 |
|
|
2015
Q1 | $392K | Buy |
13,637
+6,575
| +93% | +$189K | 0.18% | 212 |
|
|
2014
Q4 | $192K | Hold |
7,062
| – | – | 0.09% | 120 |
|
|
2014
Q3 | $150 | Hold |
7,062
| – | – | ﹤0.01% | 140 |
|
|
2014
Q2 | $159K | Buy |
+7,062
| New | +$159K | 0.12% | 174 |
|